Xero Limited (ASX: XRO) has become the dominating player in the business and accounting software market in Australia, New Zealand and the UK, since being founded in New Zealand in 2006. Employing more than 2,300 people, today Xero helps more than 1.8 million subscribers manage their accounting and tax obligations.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.51% to 6925.50.
Pro Medicus Limited (ASX: PME) was a standout, adding 12.4%. The radiology imaging technology firm announced another $140 million ten year contract in the US as the business continues to scale quickly.
Another 4% fall in the price of iron ore was almost enough to drive the S&P/ASX200 (INDEXASX: XJO) lower, with the materials sector falling 0.7% to open the week.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.37% to 7065.20.
The Xero Limited (ASX:XRO) share price has done exceptionally well in 2023, it’s up by 60% in 2023. Could the ASX tech share still be a buy?
A tech slide dragged the ASX indices lower on Wednesday, ahead of the US inflation data coming in overnight.
Want to find the top 10 best ASX shares in Australia? Luke Laretive and Owen Rask go head-to-head in the search for multibaggers on the ASX, with some shocking stats.
When I woke up this week and saw that the Altium Limited (ASX: ALU) share price had jumped 25% in one day I was so disappointed. I wanted to buy some Altium shares because I noticed, surprisingly, that it hadn’t really budged since the beginning of the year.
Pro Medicus Ltd (ASX:PME) shares and Xero Limited (ASX:XRO) shares my two biggest ASX shareholdings. If you want to know why I own Pro Medicus or Xero shares, read this.
